Sanofi (SNY) EPS (Basic) Growth (1y) (2010 - 2026)
Powered by 
Analysis
Sanofi (SNY) EPS (Basic) Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | -0.10% |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 284.05% |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | -130.68% |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -15.94% |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -108.11% |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | -91.06% |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 39.99% |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 13.91% |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn | 31.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -91.06% |
| Mar 31, 2026 | -1.60% |
| Dec 31, 2025 | -1,580.29% |
| Sep 30, 2025 | 234.10% |
| Jun 30, 2025 | 281.65% |
| Mar 31, 2025 | 60.02% |
| Dec 31, 2024 | 189.32% |
| Sep 30, 2024 | 12.49% |
| Jun 30, 2024 | -23.28% |
| Mar 31, 2024 | -42.51% |
| Dec 31, 2023 | -111.13% |
| Sep 30, 2023 | 31.38% |
| Jun 30, 2023 | 24.69% |
| Mar 31, 2023 | -4.99% |
| Dec 31, 2022 | -7.50% |
| Sep 30, 2022 | -23.09% |
| Jun 30, 2022 | -13.02% |
| Mar 31, 2022 | 19.47% |
| Dec 31, 2021 | -56.62% |
| Sep 30, 2021 | 19.12% |